BackPear Therapeutics Overview
Pear Therapeutics Inc - Class A

Pear Therapeutics Target Price

Analysts' 12-month price predictions for PEAR.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.03

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-11-16Citigroup$517023.3% upsideOpen
2022-11-15Chardan Capital$827297.3% upsideOpen